Showing results (451-460 of 513) with videos related to

Sort By:
Pageof 52
Ebiomedicine|March 16, 2024
Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancerSehhoon Park, Tae Hee Hong, Soohyun Hwang, et al.
Journal of Translational Medicine|October 18, 2023
Genetic assessment of pathogenic germline alterations in lysosomal genes among Asian patients with pancreatic ductal adenocarcinomaYoungil Koh, Hyemin Kim, So Young Joo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 30, 2026
Long-Term Impact of First-Line Amivantamab Plus Lazertinib Versus Osimertinib on Mechanisms of Acquired Resistance in MARIPOSA: A Brief ReportHidetoshi Hayashi, Byoung Chul Cho, David R Spigel, et al.
Experimental & Molecular Medicine|April 21, 2026
Enhanced multicancer screening assay through whole-genome methylation sequencing-based multimodal cell-free DNA analysisSeongmun Jeong, Dayoung Go, Yujin Jeon, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2005
Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapyJeeyun Lee, Yeon Hee Park, Won Seog Kim, et al.
Cancer Research Communications|November 10, 2025
Deep Learning Predicts EGFR Mutation Status from Histology Images in Non-Small Cell Lung CancerJongchan Park, Sangwon Shin, Woochan Hwang, et al.
Iscience|August 16, 2020
Earlier-Phased Cancer Immunity Cycle Strongly Influences Cancer Immunity in Operable Never-Smoker Lung AdenocarcinomaHong Kwan Kim, Je-Gun Joung, Yoon-La Choi, et al.
Clinical Lung Cancer|March 10, 2026
Subcutaneous Delivery of Amivantamab in Patients With Advanced Solid Malignancies: The Phase Ib PALOMA StudyAnna Minchom, Byoung Chul Cho, Natasha B Leighl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 27, 2015
Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG-HN10-02)Ji Yun Lee, Jong-Mu Sun, Dong Ryul Oh, et al.
JTO Clinical and Research Reports|December 2, 2024
Clinical Outcomes of Maintenance Durvalumab After Definitive Concurrent Chemoradiotherapy in Unresectable Locally Advanced Stage III NSCLC According to EGFR and ALK Status: Korean Cancer Study Group LU-22-18Dae-Ho Choi, Miso Kim, Young Saing Kim, et al.
Pageof 52